Tag: RapidAI

Penumbra Announces Partnership with RapidAI to Enable Faster Clinical Decision-Making for Pulmonary Embolism

ALAMEDA, Calif., Nov. 10, 2020 /PRNewswire/ — Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced a new partnership to develop solutions to enable faster clinical decision-making for pulmonary embolism (PE) diagnosis and procedures with RapidAI, a company […]